|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.54 USD | +1.98% |
|
-0.42% | -1.91% |
| 02:43pm | Vera Therapeutics Appoints David Johnson as Chief Operating Officer | MT |
| 12:45pm | Pfizer Inc Appoints Cyrus Taraporevala to Board of Directors, Audit Committee and Compensation Committee | CI |
Health-care companies rose, but not by as much as the broad market, after mixed earnings from one Big Pharma company.
Pfizer shares ticked up after the drug maker forecast 2023 revenue ahead of some investors' expectations. Pfizer said revenue for the year would plunge from about $100 billion in 2022 to a range of $67 billion to $71 billion, as demand for Covid 19 products was set to dry up.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-31-23 1703ET
| 1st Jan change | Capi. | |
|---|---|---|
| -1.91% | 159B | |
| +56.55% | 815B | |
| +43.27% | 641B | |
| -6.24% | 352B | |
| +17.23% | 314B | |
| +10.22% | 303B | |
| +15.88% | 242B | |
| +2.21% | 224B | |
| +13.63% | 218B | |
| +10.04% | 168B |
PFIZER, INC. 
